Clinical Trial Update: Safety, Efficacy and Treatment Regimen Study of ST266 in Subjects With Moderate to Severe Periodontitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on ST266 for moderate to severe periodontitis; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontal Disease

Drugs mentioned

• ST266

Snippet

Sponsor: Noveome Biotherapeutics, formerly Stemnion | Conditions: Periodontal Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-06-24